Radiosurgery Plus NovoTTF-200A for Metastatic Small Cell Lung Cancer to the Brain (RAD 1704)

NCT03488472 NA TERMINATED Results posted

This study is a prospective single arm trial designed to study the safety and effectiveness of a medical device, NovoTTF-200A, used with stereotactic radiosurgery (SRS) in subjects with brain metastases from small cell lung cancer (SCLC).

Details

Lead sponsor	Drexell Hunter Boggs
Phase	NA
Status	TERMINATED
Enrolment	1
Start date	Fri Aug 09 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Tue Feb 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Brain Metastases
• Small Cell Lung Cancer

Interventions

• NovoTTF-200A
• Stereotactic Radiosurgery (SRS)

Countries

United States